nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Temozolomide—melanoma	0.476	0.556	CiPCiCtD
Carmustine—Alkylating Activity—Dacarbazine—melanoma	0.381	0.444	CiPCiCtD
Carmustine—CYP1A2—Vemurafenib—melanoma	0.0355	0.566	CbGbCtD
Carmustine—CYP1A2—Dacarbazine—melanoma	0.0272	0.434	CbGbCtD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—PRDX2—melanoma	0.00188	0.117	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC39A12—melanoma	0.000996	0.0619	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—PRDX2—melanoma	0.000729	0.0453	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—EPHA2—melanoma	0.000486	0.0302	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—ASF1A—melanoma	0.00047	0.0292	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC6A11—melanoma	0.000457	0.0284	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—AKR1B10—melanoma	0.000385	0.0239	CbGpPWpGaD
Carmustine—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—melanoma	0.000354	0.022	CbGpPWpGaD
Carmustine—Skin exfoliation—Bleomycin—melanoma	0.000321	0.005	CcSEcCtD
Carmustine—Skin hyperpigmentation—Docetaxel—melanoma	0.000317	0.00494	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—ARNT—melanoma	0.000314	0.0195	CbGpPWpGaD
Carmustine—Febrile neutropenia—Docetaxel—melanoma	0.000313	0.00489	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—GPAM—melanoma	0.000304	0.0189	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Vemurafenib—melanoma	0.000304	0.00474	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—PRDX2—melanoma	0.000303	0.0188	CbGpPWpGaD
Carmustine—Oral candidiasis—Docetaxel—melanoma	0.000297	0.00463	CcSEcCtD
Carmustine—Gait disturbance—Temozolomide—melanoma	0.00029	0.00453	CcSEcCtD
Carmustine—Coordination abnormal—Temozolomide—melanoma	0.000289	0.0045	CcSEcCtD
Carmustine—Pulmonary embolism—Temozolomide—melanoma	0.000283	0.00442	CcSEcCtD
Carmustine—Phlebitis—Bleomycin—melanoma	0.000283	0.00442	CcSEcCtD
Carmustine—Cyst—Docetaxel—melanoma	0.000282	0.0044	CcSEcCtD
Carmustine—Oedema peripheral—Vemurafenib—melanoma	0.000274	0.00428	CcSEcCtD
Carmustine—Urinary incontinence—Temozolomide—melanoma	0.000274	0.00427	CcSEcCtD
Carmustine—Depressed level of consciousness—Temozolomide—melanoma	0.000274	0.00427	CcSEcCtD
Carmustine—Connective tissue disorder—Vemurafenib—melanoma	0.000274	0.00427	CcSEcCtD
Carmustine—Sepsis—Dactinomycin—melanoma	0.000272	0.00424	CcSEcCtD
Carmustine—Burning sensation—Docetaxel—melanoma	0.000271	0.00423	CcSEcCtD
Carmustine—Skin exfoliation—Temozolomide—melanoma	0.000271	0.00422	CcSEcCtD
Carmustine—Candida infection—Temozolomide—melanoma	0.000271	0.00422	CcSEcCtD
Carmustine—GSR—Oxidative Stress—NFKB1—melanoma	0.000269	0.0167	CbGpPWpGaD
Carmustine—Interstitial lung disease—Docetaxel—melanoma	0.000266	0.00415	CcSEcCtD
Carmustine—Neuropathy—Temozolomide—melanoma	0.000266	0.00415	CcSEcCtD
Carmustine—Injury—Bleomycin—melanoma	0.000265	0.00414	CcSEcCtD
Carmustine—Phlebitis—Dactinomycin—melanoma	0.000264	0.00412	CcSEcCtD
Carmustine—Eye disorder—Vemurafenib—melanoma	0.00026	0.00406	CcSEcCtD
Carmustine—Neoplasm—Temozolomide—melanoma	0.000256	0.004	CcSEcCtD
Carmustine—Scotoma—Docetaxel—melanoma	0.000248	0.00387	CcSEcCtD
Carmustine—Abnormal vision—Temozolomide—melanoma	0.000247	0.00386	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—POT1—melanoma	0.000247	0.0153	CbGpPWpGaD
Carmustine—Alopecia—Vemurafenib—melanoma	0.000246	0.00384	CcSEcCtD
Carmustine—Mental disability—Temozolomide—melanoma	0.000246	0.00384	CcSEcCtD
Carmustine—Hepatotoxicity—Docetaxel—melanoma	0.000244	0.00381	CcSEcCtD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.000243	0.0151	CbGpPWpGaD
Carmustine—Malnutrition—Vemurafenib—melanoma	0.000242	0.00378	CcSEcCtD
Carmustine—Erythema—Vemurafenib—melanoma	0.000242	0.00378	CcSEcCtD
Carmustine—Necrosis—Docetaxel—melanoma	0.00024	0.00375	CcSEcCtD
Carmustine—Thrombophlebitis—Temozolomide—melanoma	0.000238	0.00371	CcSEcCtD
Carmustine—Back pain—Vemurafenib—melanoma	0.000235	0.00366	CcSEcCtD
Carmustine—Eye pain—Temozolomide—melanoma	0.000228	0.00355	CcSEcCtD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.000221	0.0138	CbGpPWpGaD
Carmustine—Amnesia—Temozolomide—melanoma	0.000219	0.00342	CcSEcCtD
Carmustine—Extravasation—Docetaxel—melanoma	0.000216	0.00337	CcSEcCtD
Carmustine—Liver function test abnormal—Dactinomycin—melanoma	0.00021	0.00328	CcSEcCtD
Carmustine—GSR—NRF2 pathway—SLC5A5—melanoma	0.000209	0.013	CbGpPWpGaD
Carmustine—Myalgia—Vemurafenib—melanoma	0.000206	0.00322	CcSEcCtD
Carmustine—Diplopia—Temozolomide—melanoma	0.000206	0.00321	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—ID1—melanoma	0.000205	0.0127	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAP3K5—melanoma	0.000205	0.0127	CbGpPWpGaD
Carmustine—Drug interaction—Docetaxel—melanoma	0.000203	0.00317	CcSEcCtD
Carmustine—Pancytopenia—Bleomycin—melanoma	0.0002	0.00312	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP17A1—melanoma	0.000199	0.0124	CbGpPWpGaD
Carmustine—Face oedema—Temozolomide—melanoma	0.000199	0.0031	CcSEcCtD
Carmustine—Dysphagia—Dactinomycin—melanoma	0.000197	0.00307	CcSEcCtD
Carmustine—Infection—Vemurafenib—melanoma	0.000197	0.00307	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—MAP2—melanoma	0.000194	0.0121	CbGpPWpGaD
Carmustine—Ataxia—Temozolomide—melanoma	0.000193	0.00302	CcSEcCtD
Carmustine—Pneumonia—Bleomycin—melanoma	0.000189	0.00295	CcSEcCtD
Carmustine—Pulmonary embolism—Docetaxel—melanoma	0.000189	0.00294	CcSEcCtD
Carmustine—Injection site reaction—Docetaxel—melanoma	0.000187	0.00292	CcSEcCtD
Carmustine—Hypokalaemia—Temozolomide—melanoma	0.000187	0.00292	CcSEcCtD
Carmustine—Pancytopenia—Dactinomycin—melanoma	0.000187	0.00291	CcSEcCtD
Carmustine—Hypotension—Vemurafenib—melanoma	0.000185	0.00288	CcSEcCtD
Carmustine—Neutropenia—Dactinomycin—melanoma	0.000184	0.00287	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—HDAC6—melanoma	0.000183	0.0114	CbGpPWpGaD
Carmustine—Stomatitis—Bleomycin—melanoma	0.000183	0.00286	CcSEcCtD
Carmustine—Muscular weakness—Temozolomide—melanoma	0.000181	0.00283	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00018	0.00281	CcSEcCtD
Carmustine—Candida infection—Docetaxel—melanoma	0.00018	0.00281	CcSEcCtD
Carmustine—Skin exfoliation—Docetaxel—melanoma	0.00018	0.00281	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—ICAM1—melanoma	0.000179	0.0111	CbGpPWpGaD
Carmustine—Dysphagia—Temozolomide—melanoma	0.000178	0.00277	CcSEcCtD
Carmustine—Neuropathy—Docetaxel—melanoma	0.000177	0.00276	CcSEcCtD
Carmustine—Pneumonia—Dactinomycin—melanoma	0.000176	0.00275	CcSEcCtD
Carmustine—Decreased appetite—Vemurafenib—melanoma	0.000172	0.00268	CcSEcCtD
Carmustine—Stomatitis—Dactinomycin—melanoma	0.000171	0.00267	CcSEcCtD
Carmustine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000171	0.00266	CcSEcCtD
Carmustine—Neoplasm—Docetaxel—melanoma	0.00017	0.00266	CcSEcCtD
Carmustine—Haemoglobin—Bleomycin—melanoma	0.00017	0.00265	CcSEcCtD
Carmustine—Constipation—Vemurafenib—melanoma	0.000169	0.00264	CcSEcCtD
Carmustine—Pancytopenia—Temozolomide—melanoma	0.000169	0.00263	CcSEcCtD
Carmustine—Haemorrhage—Bleomycin—melanoma	0.000169	0.00263	CcSEcCtD
Carmustine—Hypoaesthesia—Bleomycin—melanoma	0.000168	0.00262	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP1B1—melanoma	0.000168	0.0104	CbGpPWpGaD
Carmustine—Neutropenia—Temozolomide—melanoma	0.000166	0.00259	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1B1—melanoma	0.000165	0.0103	CbGpPWpGaD
Carmustine—Sepsis—Docetaxel—melanoma	0.000164	0.00255	CcSEcCtD
Carmustine—Hyperglycaemia—Temozolomide—melanoma	0.00016	0.0025	CcSEcCtD
Carmustine—Pneumonia—Temozolomide—melanoma	0.000159	0.00249	CcSEcCtD
Carmustine—Phlebitis—Docetaxel—melanoma	0.000159	0.00248	CcSEcCtD
Carmustine—Depression—Temozolomide—melanoma	0.000158	0.00247	CcSEcCtD
Carmustine—Thrombophlebitis—Docetaxel—melanoma	0.000158	0.00247	CcSEcCtD
Carmustine—Flushing—Bleomycin—melanoma	0.000157	0.00244	CcSEcCtD
Carmustine—Body temperature increased—Vemurafenib—melanoma	0.000156	0.00244	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ARNT—melanoma	0.000156	0.0097	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.000156	0.0097	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Temozolomide—melanoma	0.000155	0.00242	CcSEcCtD
Carmustine—Swelling—Docetaxel—melanoma	0.000155	0.00242	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—ETS1—melanoma	0.000155	0.00963	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HGF—melanoma	0.000155	0.00962	CbGpPWpGaD
Carmustine—Stomatitis—Temozolomide—melanoma	0.000155	0.00241	CcSEcCtD
Carmustine—Urinary tract infection—Temozolomide—melanoma	0.000154	0.0024	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—ALB—melanoma	0.00015	0.00929	CbGpPWpGaD
Carmustine—Alopecia—Bleomycin—melanoma	0.000149	0.00233	CcSEcCtD
Carmustine—Erythema—Bleomycin—melanoma	0.000147	0.00229	CcSEcCtD
Carmustine—Flushing—Dactinomycin—melanoma	0.000146	0.00228	CcSEcCtD
Carmustine—Hypersensitivity—Vemurafenib—melanoma	0.000146	0.00227	CcSEcCtD
Carmustine—Haemoglobin—Temozolomide—melanoma	0.000143	0.00223	CcSEcCtD
Carmustine—Haemorrhage—Temozolomide—melanoma	0.000142	0.00222	CcSEcCtD
Carmustine—Asthenia—Vemurafenib—melanoma	0.000142	0.00221	CcSEcCtD
Carmustine—Hallucination—Temozolomide—melanoma	0.000142	0.00221	CcSEcCtD
Carmustine—Hypoaesthesia—Temozolomide—melanoma	0.000142	0.00221	CcSEcCtD
Carmustine—Oedema peripheral—Temozolomide—melanoma	0.00014	0.00219	CcSEcCtD
Carmustine—Connective tissue disorder—Temozolomide—melanoma	0.00014	0.00218	CcSEcCtD
Carmustine—Alopecia—Dactinomycin—melanoma	0.000139	0.00217	CcSEcCtD
Carmustine—Hyponatraemia—Docetaxel—melanoma	0.000137	0.00214	CcSEcCtD
Carmustine—Visual impairment—Temozolomide—melanoma	0.000137	0.00214	CcSEcCtD
Carmustine—Erythema—Dactinomycin—melanoma	0.000137	0.00214	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000137	0.00213	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—EPO—melanoma	0.000137	0.00848	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IFNG—melanoma	0.000137	0.00848	CbGpPWpGaD
Carmustine—Anaemia—Bleomycin—melanoma	0.000136	0.00212	CcSEcCtD
Carmustine—Diarrhoea—Vemurafenib—melanoma	0.000135	0.00211	CcSEcCtD
Carmustine—Eye disorder—Temozolomide—melanoma	0.000133	0.00207	CcSEcCtD
Carmustine—Flushing—Temozolomide—melanoma	0.000132	0.00206	CcSEcCtD
Carmustine—Leukopenia—Bleomycin—melanoma	0.000131	0.00205	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—melanoma	0.000131	0.00813	CbGpPWpGaD
Carmustine—Dizziness—Vemurafenib—melanoma	0.000131	0.00204	CcSEcCtD
Carmustine—Ataxia—Docetaxel—melanoma	0.000129	0.00201	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—UGT2B10—melanoma	0.000127	0.00792	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—CYP1B1—melanoma	0.000127	0.0079	CbGpPWpGaD
Carmustine—Anaemia—Dactinomycin—melanoma	0.000127	0.00197	CcSEcCtD
Carmustine—Liver function test abnormal—Docetaxel—melanoma	0.000126	0.00197	CcSEcCtD
Carmustine—Vomiting—Vemurafenib—melanoma	0.000126	0.00196	CcSEcCtD
Carmustine—Alopecia—Temozolomide—melanoma	0.000126	0.00196	CcSEcCtD
Carmustine—Myalgia—Bleomycin—melanoma	0.000125	0.00195	CcSEcCtD
Carmustine—Chest pain—Bleomycin—melanoma	0.000125	0.00195	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—IFNB1—melanoma	0.000125	0.00776	CbGpPWpGaD
Carmustine—Rash—Vemurafenib—melanoma	0.000125	0.00195	CcSEcCtD
Carmustine—Mental disorder—Temozolomide—melanoma	0.000125	0.00194	CcSEcCtD
Carmustine—Dermatitis—Vemurafenib—melanoma	0.000125	0.00194	CcSEcCtD
Carmustine—Headache—Vemurafenib—melanoma	0.000124	0.00193	CcSEcCtD
Carmustine—Malnutrition—Temozolomide—melanoma	0.000124	0.00193	CcSEcCtD
Carmustine—Erythema—Temozolomide—melanoma	0.000124	0.00193	CcSEcCtD
Carmustine—Leukopenia—Dactinomycin—melanoma	0.000123	0.00191	CcSEcCtD
Carmustine—Confusional state—Bleomycin—melanoma	0.000121	0.00189	CcSEcCtD
Carmustine—Oedema—Bleomycin—melanoma	0.00012	0.00187	CcSEcCtD
Carmustine—Back pain—Temozolomide—melanoma	0.00012	0.00187	CcSEcCtD
Carmustine—Infection—Bleomycin—melanoma	0.000119	0.00186	CcSEcCtD
Carmustine—Dysphagia—Docetaxel—melanoma	0.000118	0.00184	CcSEcCtD
Carmustine—Nausea—Vemurafenib—melanoma	0.000118	0.00183	CcSEcCtD
Carmustine—Thrombocytopenia—Bleomycin—melanoma	0.000117	0.00183	CcSEcCtD
Carmustine—Vision blurred—Temozolomide—melanoma	0.000117	0.00182	CcSEcCtD
Carmustine—Myalgia—Dactinomycin—melanoma	0.000117	0.00182	CcSEcCtD
Carmustine—Tremor—Temozolomide—melanoma	0.000116	0.00181	CcSEcCtD
Carmustine—Anaemia—Temozolomide—melanoma	0.000115	0.00179	CcSEcCtD
Carmustine—Anorexia—Bleomycin—melanoma	0.000114	0.00178	CcSEcCtD
Carmustine—Agitation—Temozolomide—melanoma	0.000114	0.00178	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—NFKB1—melanoma	0.000114	0.00706	CbGpPWpGaD
Carmustine—GSR—Metabolism—ACER3—melanoma	0.000113	0.00703	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1B1—melanoma	0.000112	0.00699	CbGpPWpGaD
Carmustine—Pancytopenia—Docetaxel—melanoma	0.000112	0.00175	CcSEcCtD
Carmustine—Hypotension—Bleomycin—melanoma	0.000112	0.00175	CcSEcCtD
Carmustine—Oedema—Dactinomycin—melanoma	0.000112	0.00174	CcSEcCtD
Carmustine—Infection—Dactinomycin—melanoma	0.000111	0.00173	CcSEcCtD
Carmustine—Leukopenia—Temozolomide—melanoma	0.000111	0.00173	CcSEcCtD
Carmustine—Neutropenia—Docetaxel—melanoma	0.000111	0.00172	CcSEcCtD
Carmustine—Thrombocytopenia—Dactinomycin—melanoma	0.000109	0.00171	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000109	0.0017	CcSEcCtD
Carmustine—Paraesthesia—Bleomycin—melanoma	0.000108	0.00168	CcSEcCtD
Carmustine—Convulsion—Temozolomide—melanoma	0.000107	0.00167	CcSEcCtD
Carmustine—Hypertension—Temozolomide—melanoma	0.000107	0.00167	CcSEcCtD
Carmustine—Dyspnoea—Bleomycin—melanoma	0.000107	0.00167	CcSEcCtD
Carmustine—Anorexia—Dactinomycin—melanoma	0.000107	0.00166	CcSEcCtD
Carmustine—Pneumonia—Docetaxel—melanoma	0.000106	0.00165	CcSEcCtD
Carmustine—Myalgia—Temozolomide—melanoma	0.000106	0.00165	CcSEcCtD
Carmustine—Anxiety—Temozolomide—melanoma	0.000105	0.00164	CcSEcCtD
Carmustine—Decreased appetite—Bleomycin—melanoma	0.000104	0.00163	CcSEcCtD
Carmustine—Renal failure—Docetaxel—melanoma	0.000104	0.00162	CcSEcCtD
Carmustine—GSR—Metabolism—UGT2B10—melanoma	0.000104	0.00643	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Docetaxel—melanoma	0.000103	0.00161	CcSEcCtD
Carmustine—Stomatitis—Docetaxel—melanoma	0.000103	0.0016	CcSEcCtD
Carmustine—Pain—Bleomycin—melanoma	0.000103	0.0016	CcSEcCtD
Carmustine—Confusional state—Temozolomide—melanoma	0.000102	0.00159	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000102	0.00159	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CDKN2B—melanoma	0.000102	0.00631	CbGpPWpGaD
Carmustine—Oedema—Temozolomide—melanoma	0.000101	0.00158	CcSEcCtD
Carmustine—Infection—Temozolomide—melanoma	0.0001	0.00157	CcSEcCtD
Carmustine—Thrombocytopenia—Temozolomide—melanoma	9.9e-05	0.00154	CcSEcCtD
Carmustine—Feeling abnormal—Bleomycin—melanoma	9.88e-05	0.00154	CcSEcCtD
Carmustine—Decreased appetite—Dactinomycin—melanoma	9.72e-05	0.00152	CcSEcCtD
Carmustine—Anorexia—Temozolomide—melanoma	9.64e-05	0.0015	CcSEcCtD
Carmustine—GSR—Metabolism—HS3ST5—melanoma	9.63e-05	0.00598	CbGpPWpGaD
Carmustine—Pain—Dactinomycin—melanoma	9.56e-05	0.00149	CcSEcCtD
Carmustine—Haemoglobin—Docetaxel—melanoma	9.51e-05	0.00148	CcSEcCtD
Carmustine—Body temperature increased—Bleomycin—melanoma	9.48e-05	0.00148	CcSEcCtD
Carmustine—Haemorrhage—Docetaxel—melanoma	9.47e-05	0.00148	CcSEcCtD
Carmustine—Hypoaesthesia—Docetaxel—melanoma	9.42e-05	0.00147	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—E2F1—melanoma	9.33e-05	0.00579	CbGpPWpGaD
Carmustine—Oedema peripheral—Docetaxel—melanoma	9.33e-05	0.00145	CcSEcCtD
Carmustine—Connective tissue disorder—Docetaxel—melanoma	9.3e-05	0.00145	CcSEcCtD
Carmustine—Feeling abnormal—Dactinomycin—melanoma	9.21e-05	0.00144	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Temozolomide—melanoma	9.21e-05	0.00144	CcSEcCtD
Carmustine—Insomnia—Temozolomide—melanoma	9.15e-05	0.00143	CcSEcCtD
Carmustine—Gastrointestinal pain—Dactinomycin—melanoma	9.14e-05	0.00143	CcSEcCtD
Carmustine—Visual impairment—Docetaxel—melanoma	9.12e-05	0.00142	CcSEcCtD
Carmustine—Paraesthesia—Temozolomide—melanoma	9.08e-05	0.00142	CcSEcCtD
Carmustine—Dyspnoea—Temozolomide—melanoma	9.02e-05	0.00141	CcSEcCtD
Carmustine—Somnolence—Temozolomide—melanoma	8.99e-05	0.0014	CcSEcCtD
Carmustine—Eye disorder—Docetaxel—melanoma	8.85e-05	0.00138	CcSEcCtD
Carmustine—Body temperature increased—Dactinomycin—melanoma	8.84e-05	0.00138	CcSEcCtD
Carmustine—Abdominal pain—Dactinomycin—melanoma	8.84e-05	0.00138	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—TNF—melanoma	8.83e-05	0.00549	CbGpPWpGaD
Carmustine—Hypersensitivity—Bleomycin—melanoma	8.83e-05	0.00138	CcSEcCtD
Carmustine—Decreased appetite—Temozolomide—melanoma	8.79e-05	0.00137	CcSEcCtD
Carmustine—Flushing—Docetaxel—melanoma	8.79e-05	0.00137	CcSEcCtD
Carmustine—Gastrointestinal disorder—Temozolomide—melanoma	8.73e-05	0.00136	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1B1—melanoma	8.69e-05	0.0054	CbGpPWpGaD
Carmustine—Pain—Temozolomide—melanoma	8.65e-05	0.00135	CcSEcCtD
Carmustine—Constipation—Temozolomide—melanoma	8.65e-05	0.00135	CcSEcCtD
Carmustine—Asthenia—Bleomycin—melanoma	8.6e-05	0.00134	CcSEcCtD
Carmustine—Arrhythmia—Docetaxel—melanoma	8.46e-05	0.00132	CcSEcCtD
Carmustine—Alopecia—Docetaxel—melanoma	8.37e-05	0.0013	CcSEcCtD
Carmustine—Feeling abnormal—Temozolomide—melanoma	8.33e-05	0.0013	CcSEcCtD
Carmustine—Mental disorder—Docetaxel—melanoma	8.29e-05	0.00129	CcSEcCtD
Carmustine—Gastrointestinal pain—Temozolomide—melanoma	8.27e-05	0.00129	CcSEcCtD
Carmustine—Erythema—Docetaxel—melanoma	8.24e-05	0.00129	CcSEcCtD
Carmustine—Malnutrition—Docetaxel—melanoma	8.24e-05	0.00129	CcSEcCtD
Carmustine—Hypersensitivity—Dactinomycin—melanoma	8.24e-05	0.00128	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—HIF1A—melanoma	8.12e-05	0.00505	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDK2—melanoma	8.04e-05	0.005	CbGpPWpGaD
Carmustine—Asthenia—Dactinomycin—melanoma	8.02e-05	0.00125	CcSEcCtD
Carmustine—Body temperature increased—Temozolomide—melanoma	8e-05	0.00125	CcSEcCtD
Carmustine—Abdominal pain—Temozolomide—melanoma	8e-05	0.00125	CcSEcCtD
Carmustine—Back pain—Docetaxel—melanoma	7.97e-05	0.00124	CcSEcCtD
Carmustine—Diarrhoea—Dactinomycin—melanoma	7.65e-05	0.00119	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—ATM—melanoma	7.64e-05	0.00474	CbGpPWpGaD
Carmustine—Vomiting—Bleomycin—melanoma	7.62e-05	0.00119	CcSEcCtD
Carmustine—Anaemia—Docetaxel—melanoma	7.62e-05	0.00119	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CDK4—melanoma	7.6e-05	0.00472	CbGpPWpGaD
Carmustine—Rash—Bleomycin—melanoma	7.56e-05	0.00118	CcSEcCtD
Carmustine—Dermatitis—Bleomycin—melanoma	7.55e-05	0.00118	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—UGT2B10—melanoma	7.45e-05	0.00463	CbGpPWpGaD
Carmustine—Hypersensitivity—Temozolomide—melanoma	7.45e-05	0.00116	CcSEcCtD
Carmustine—Leukopenia—Docetaxel—melanoma	7.38e-05	0.00115	CcSEcCtD
Carmustine—GSR—Metabolism—PLCB4—melanoma	7.3e-05	0.00453	CbGpPWpGaD
Carmustine—Asthenia—Temozolomide—melanoma	7.26e-05	0.00113	CcSEcCtD
Carmustine—Convulsion—Docetaxel—melanoma	7.14e-05	0.00111	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL6—melanoma	7.13e-05	0.00443	CbGpPWpGaD
Carmustine—Nausea—Bleomycin—melanoma	7.12e-05	0.00111	CcSEcCtD
Carmustine—Hypertension—Docetaxel—melanoma	7.11e-05	0.00111	CcSEcCtD
Carmustine—Vomiting—Dactinomycin—melanoma	7.11e-05	0.00111	CcSEcCtD
Carmustine—Rash—Dactinomycin—melanoma	7.05e-05	0.0011	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—EDN1—melanoma	7.02e-05	0.00436	CbGpPWpGaD
Carmustine—Chest pain—Docetaxel—melanoma	7.02e-05	0.00109	CcSEcCtD
Carmustine—Myalgia—Docetaxel—melanoma	7.02e-05	0.00109	CcSEcCtD
Carmustine—Diarrhoea—Temozolomide—melanoma	6.92e-05	0.00108	CcSEcCtD
Carmustine—GSR—Metabolism—PIP4K2A—melanoma	6.86e-05	0.00426	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC6A11—melanoma	6.86e-05	0.00426	CbGpPWpGaD
Carmustine—Confusional state—Docetaxel—melanoma	6.78e-05	0.00106	CcSEcCtD
Carmustine—Oedema—Docetaxel—melanoma	6.73e-05	0.00105	CcSEcCtD
Carmustine—Dizziness—Temozolomide—melanoma	6.69e-05	0.00104	CcSEcCtD
Carmustine—Infection—Docetaxel—melanoma	6.68e-05	0.00104	CcSEcCtD
Carmustine—GSR—Metabolism—MTAP—melanoma	6.67e-05	0.00415	CbGpPWpGaD
Carmustine—Nausea—Dactinomycin—melanoma	6.64e-05	0.00104	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—RB1—melanoma	6.61e-05	0.00411	CbGpPWpGaD
Carmustine—Thrombocytopenia—Docetaxel—melanoma	6.59e-05	0.00103	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—PRKCA—melanoma	6.58e-05	0.00409	CbGpPWpGaD
Carmustine—Tachycardia—Docetaxel—melanoma	6.56e-05	0.00102	CcSEcCtD
Carmustine—Vomiting—Temozolomide—melanoma	6.43e-05	0.001	CcSEcCtD
Carmustine—Anorexia—Docetaxel—melanoma	6.41e-05	0.001	CcSEcCtD
Carmustine—Rash—Temozolomide—melanoma	6.38e-05	0.000994	CcSEcCtD
Carmustine—Dermatitis—Temozolomide—melanoma	6.37e-05	0.000994	CcSEcCtD
Carmustine—Headache—Temozolomide—melanoma	6.34e-05	0.000988	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	6.3e-05	0.00391	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	6.28e-05	0.0039	CbGpPWpGaD
Carmustine—Hypotension—Docetaxel—melanoma	6.28e-05	0.00098	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—melanoma	6.13e-05	0.000956	CcSEcCtD
Carmustine—Insomnia—Docetaxel—melanoma	6.08e-05	0.000949	CcSEcCtD
Carmustine—Paraesthesia—Docetaxel—melanoma	6.04e-05	0.000942	CcSEcCtD
Carmustine—Nausea—Temozolomide—melanoma	6.01e-05	0.000937	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	6e-05	0.00373	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—melanoma	6e-05	0.00373	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1B1—melanoma	6e-05	0.00373	CbGpPWpGaD
Carmustine—Dyspnoea—Docetaxel—melanoma	6e-05	0.000935	CcSEcCtD
Carmustine—Somnolence—Docetaxel—melanoma	5.98e-05	0.000932	CcSEcCtD
Carmustine—GSR—Metabolism—LUM—melanoma	5.95e-05	0.0037	CbGpPWpGaD
Carmustine—GSR—Metabolism—PHGDH—melanoma	5.95e-05	0.0037	CbGpPWpGaD
Carmustine—Decreased appetite—Docetaxel—melanoma	5.85e-05	0.000912	CcSEcCtD
Carmustine—GSR—Metabolism—HPSE—melanoma	5.83e-05	0.00362	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2A—melanoma	5.81e-05	0.00361	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Docetaxel—melanoma	5.81e-05	0.000906	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—melanoma	5.8e-05	0.0036	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	5.77e-05	0.00358	CbGpPWpGaD
Carmustine—Pain—Docetaxel—melanoma	5.75e-05	0.000897	CcSEcCtD
Carmustine—Constipation—Docetaxel—melanoma	5.75e-05	0.000897	CcSEcCtD
Carmustine—GSR—Metabolism—CUBN—melanoma	5.73e-05	0.00356	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—melanoma	5.69e-05	0.00354	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MDM2—melanoma	5.64e-05	0.0035	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1B1—melanoma	5.62e-05	0.00349	CbGpPWpGaD
Carmustine—Feeling abnormal—Docetaxel—melanoma	5.54e-05	0.000864	CcSEcCtD
Carmustine—GSR—Metabolism—SDHD—melanoma	5.53e-05	0.00344	CbGpPWpGaD
Carmustine—GSR—Metabolism—BSG—melanoma	5.53e-05	0.00344	CbGpPWpGaD
Carmustine—GSR—Metabolism—CSPG4—melanoma	5.53e-05	0.00344	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Docetaxel—melanoma	5.5e-05	0.000858	CcSEcCtD
Carmustine—GSR—Metabolism—GPAM—melanoma	5.36e-05	0.00333	CbGpPWpGaD
Carmustine—Abdominal pain—Docetaxel—melanoma	5.32e-05	0.000829	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—melanoma	5.32e-05	0.000829	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CXCL8—melanoma	5.27e-05	0.00327	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1B—melanoma	5.15e-05	0.0032	CbGpPWpGaD
Carmustine—Hypersensitivity—Docetaxel—melanoma	4.96e-05	0.000773	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	4.85e-05	0.00302	CbGpPWpGaD
Carmustine—Asthenia—Docetaxel—melanoma	4.83e-05	0.000753	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—melanoma	4.79e-05	0.00298	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1A—melanoma	4.75e-05	0.00295	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—AKR1B10—melanoma	4.74e-05	0.00294	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—NFKB1—melanoma	4.72e-05	0.00293	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	4.68e-05	0.0029	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—melanoma	4.65e-05	0.00289	CbGpPWpGaD
Carmustine—Diarrhoea—Docetaxel—melanoma	4.6e-05	0.000718	CcSEcCtD
Carmustine—GSR—Metabolism—PLA2G6—melanoma	4.55e-05	0.00283	CbGpPWpGaD
Carmustine—Dizziness—Docetaxel—melanoma	4.45e-05	0.000694	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	4.38e-05	0.00272	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—melanoma	4.28e-05	0.00266	CbGpPWpGaD
Carmustine—Vomiting—Docetaxel—melanoma	4.28e-05	0.000667	CcSEcCtD
Carmustine—Rash—Docetaxel—melanoma	4.24e-05	0.000661	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—STAT3—melanoma	4.24e-05	0.00263	CbGpPWpGaD
Carmustine—Dermatitis—Docetaxel—melanoma	4.24e-05	0.000661	CcSEcCtD
Carmustine—Headache—Docetaxel—melanoma	4.21e-05	0.000657	CcSEcCtD
Carmustine—GSR—Metabolism—VCAN—melanoma	4.09e-05	0.00254	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK3—melanoma	4.05e-05	0.00252	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	4.01e-05	0.00249	CbGpPWpGaD
Carmustine—Nausea—Docetaxel—melanoma	4e-05	0.000623	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.94e-05	0.00245	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK1—melanoma	3.85e-05	0.00239	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP17A1—melanoma	3.45e-05	0.00214	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	3.4e-05	0.00211	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	3.29e-05	0.00205	CbGpPWpGaD
Carmustine—GSR—Metabolism—GNA11—melanoma	3.26e-05	0.00202	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TP53—melanoma	3.23e-05	0.00201	CbGpPWpGaD
Carmustine—GSR—Metabolism—FASN—melanoma	3.19e-05	0.00198	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	3.15e-05	0.00196	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC5A5—melanoma	3.14e-05	0.00195	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	3.13e-05	0.00194	CbGpPWpGaD
Carmustine—GSR—Metabolism—CD44—melanoma	3.03e-05	0.00188	CbGpPWpGaD
Carmustine—GSR—Metabolism—GNAQ—melanoma	3.03e-05	0.00188	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—melanoma	2.96e-05	0.00184	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP1B1—melanoma	2.91e-05	0.0018	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	2.82e-05	0.00175	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—melanoma	2.81e-05	0.00174	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	2.71e-05	0.00168	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	2.56e-05	0.00159	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	2.56e-05	0.00159	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	2.53e-05	0.00157	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	2.51e-05	0.00156	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP17A1—melanoma	2.48e-05	0.00154	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	2.45e-05	0.00152	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCB1—melanoma	2.39e-05	0.00149	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	2.37e-05	0.00147	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	2.35e-05	0.00146	CbGpPWpGaD
Carmustine—GSR—Metabolism—PRKCA—melanoma	2.2e-05	0.00137	CbGpPWpGaD
Carmustine—GSR—Metabolism—ERCC2—melanoma	2.18e-05	0.00136	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	2.13e-05	0.00132	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	2.11e-05	0.00131	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP1B1—melanoma	2.09e-05	0.0013	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	2.06e-05	0.00128	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	1.96e-05	0.00122	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	1.92e-05	0.00119	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	1.92e-05	0.00119	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	1.92e-05	0.00119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	1.9e-05	0.00118	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	1.83e-05	0.00114	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	1.83e-05	0.00114	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	1.81e-05	0.00113	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—melanoma	1.72e-05	0.00107	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—melanoma	1.66e-05	0.00103	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	1.58e-05	0.000983	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	1.54e-05	0.000957	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—melanoma	1.52e-05	0.000942	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALB—melanoma	1.5e-05	0.00093	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.48e-05	0.00092	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ACER3—melanoma	1.39e-05	0.000866	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—melanoma	1.32e-05	0.000821	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—melanoma	1.31e-05	0.000813	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UGT2B10—melanoma	1.27e-05	0.000792	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.26e-05	0.000782	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HS3ST5—melanoma	1.19e-05	0.000736	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—melanoma	1.14e-05	0.000709	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	9.54e-06	0.000593	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLCB4—melanoma	8.98e-06	0.000558	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	8.81e-06	0.000548	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC6A11—melanoma	8.44e-06	0.000525	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIP4K2A—melanoma	8.44e-06	0.000525	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTAP—melanoma	8.21e-06	0.00051	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—melanoma	8.06e-06	0.0005	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.03e-06	0.000499	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LUM—melanoma	7.32e-06	0.000455	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PHGDH—melanoma	7.32e-06	0.000455	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPSE—melanoma	7.18e-06	0.000446	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CUBN—melanoma	7.05e-06	0.000438	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SDHD—melanoma	6.81e-06	0.000423	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CSPG4—melanoma	6.81e-06	0.000423	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BSG—melanoma	6.81e-06	0.000423	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPAM—melanoma	6.59e-06	0.00041	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—melanoma	6.58e-06	0.000409	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLA2G6—melanoma	5.6e-06	0.000348	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—VCAN—melanoma	5.03e-06	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.77e-06	0.000296	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.6e-06	0.000286	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP17A1—melanoma	4.25e-06	0.000264	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.19e-06	0.00026	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.14e-06	0.000257	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNA11—melanoma	4.01e-06	0.000249	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FASN—melanoma	3.93e-06	0.000244	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC5A5—melanoma	3.86e-06	0.00024	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNAQ—melanoma	3.73e-06	0.000232	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CD44—melanoma	3.73e-06	0.000232	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.65e-06	0.000227	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.62e-06	0.000225	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1B1—melanoma	3.58e-06	0.000222	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.16e-06	0.000196	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—melanoma	2.94e-06	0.000183	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PRKCA—melanoma	2.71e-06	0.000168	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ERCC2—melanoma	2.69e-06	0.000167	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.23e-06	0.000138	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—melanoma	2.12e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—melanoma	2.05e-06	0.000127	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—melanoma	1.87e-06	0.000116	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—melanoma	1.84e-06	0.000114	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—melanoma	1.63e-06	0.000101	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—melanoma	1.61e-06	0.0001	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—melanoma	1.41e-06	8.73e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—melanoma	9.91e-07	6.16e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—melanoma	8.1e-07	5.03e-05	CbGpPWpGaD
